News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025
News Daily News Think You Need a Statin? AHA’s Risk Calculator May Disagree Michael O'Riordan June 28, 2024
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Daily News Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s Michael O'Riordan November 29, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Conference News ACC 2021 Poorer Neighborhoods Pose Risks for Black Patients After Acute MI L.A. McKeown May 05, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Industry News FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease July 15, 2019
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Daily News Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes Michael O'Riordan April 27, 2017
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016